×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Heal... [14]
Institute of Ch... [13]
THE STATE KEY LA... [8]
INSTITUTE OF COL... [2]
Faculty of Scien... [2]
Faculty of Educa... [1]
More...
Authors
OUYANG DEFANG [5]
WANG YITAO [3]
TAM KIN YIP [3]
LU JINJIAN [3]
KWOK HANG FAI [2]
HU HAO [2]
More...
Document Type
Journal article [12]
Book chapter [4]
Review article [3]
Book [2]
Conference paper [1]
Date Issued
2025 [1]
2024 [4]
2023 [3]
2022 [2]
2021 [3]
2020 [1]
More...
Language
英語English [16]
中文Chinese [5]
其他語言Others [1]
Source Publication
Exploring Comput... [2]
Kexue Tongbao/Ch... [2]
Neural Regenerat... [2]
11th Internation... [1]
Advanced Drug De... [1]
Biomarker Resear... [1]
More...
Indexed By
SCIE [8]
ESCI [1]
核心期刊 [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 22
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
AI-directed formulation strategy design initiates rational drug development
Journal article
Wang, Nannan, Dong, Jie, Ouyang, Defang. AI-directed formulation strategy design initiates rational drug development[J]. Journal of Controlled Release, 2025, 378, 619-636.
Authors:
Wang, Nannan
;
Dong, Jie
;
Ouyang, Defang
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
10.5
/
10.6
|
Submit date:2025/01/22
Formulation Strategy Design
Artificial Intelligence
Rational Drug Development
Poorly Water-soluble Drugs
Positive-unlabeled Learning
Partially Supervised Learning
Reflections and practices on key technical issues in the clinical translation of syndrome TCM new drugs 证候类中药新药临床转化关键技术问题的思考与实践
Review article
2024
Authors:
Tang, Jianyuan
;
Ai, Yanling
;
Liang, Dan
;
Wan, Lina
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
1.1
/
0
|
Submit date:2024/12/26
Clinical Evaluation
New Drug Development
New Traditional Chinese Medicine Drugs
Syndrome-based Traditional Chinese Medicine
Traditional Chinese Medicine Compound Formulations
Introduction to Computational Pharmaceutics
Book chapter
出自: Exploring Computational Pharmaceutics - Ai and Modeling in Pharma 4.0:John Wiley & Sons, Ltd, 2024, 页码:1-9
Authors:
Wang, Nannan
;
Wang, Wei
;
Zhong, Hao
;
Ouyang, Defang
Favorite
|
TC[Scopus]:
0
|
Submit date:2024/10/10
Artificial Intelligence
Computational Pharmaceutics
Drug Formulation Development
Machine Learning
Multiscale Simulation
Model-informed Drug Development (MIDD) Regarding Regulatory Requirements and Thinking
Book chapter
出自: Exploring Computational Pharmaceutics - AI and Modeling in Pharma 4.0:wiley, 2024, 页码:574-592
Authors:
Wang, Wei
;
Wang, Yuzhu
;
Ouyang, Defang
Favorite
|
TC[Scopus]:
0
|
Submit date:2024/10/10
Model-guided Drug Development
Regulation
Opportunities and Challenges of Artificial Intelligence (AI) in Drug Delivery
Book chapter
出自: Exploring Computational Pharmaceutics - AI and Modeling in Pharma 4.0:wiley, 2024, 页码:10-58
Authors:
Ye, Zhuyifan
;
Ouyang, Defang
Favorite
|
TC[Scopus]:
0
|
Submit date:2024/10/10
Artificial Intelligence
Deep Learning
Drug Delivery
Formulation Development
Machine Learning
Pharmaceutics
Introduction to traditional Chinese medicine (TCM) regulatory science for TCM high-quality development 面向中医药高质量发展的中药监管科学概论
Journal article
Tang, Jianyuan, Ai, Yanling, Sun, Bo, Hu, Jingqing, Zhao, Junning. Introduction to traditional Chinese medicine (TCM) regulatory science for TCM high-quality development 面向中医药高质量发展的中药监管科学概论[J]. Kexue Tongbao/Chinese Science Bulletin, 2023, 68(22), 2934-2942.
Authors:
Tang, Jianyuan
;
Ai, Yanling
;
Sun, Bo
;
Hu, Jingqing
;
Zhao, Junning
Favorite
|
TC[WOS]:
1
TC[Scopus]:
2
IF:
1.1
/
0
|
Submit date:2024/02/22
Drug Regulation Science
High-quality Development
Inheritance And Innovation
Traditional Chinese Medicine Regulation
Traditional Chinese Medicine Regulation Science
Chemical mitophagy modulators: Drug development strategies and novel regulatory mechanisms
Journal article
Dong,Yu, Zhuang,Xu Xu, Wang,Yi Ting, Tan,Jieqiong, Feng,Du, Li,Min, Zhong,Qing, Song,Zhiyin, Shen,Han Ming, Fang,Evandro F., Lu,Jia Hong. Chemical mitophagy modulators: Drug development strategies and novel regulatory mechanisms[J]. Pharmacological Research, 2023, 194, 106835.
Authors:
Dong,Yu
;
Zhuang,Xu Xu
;
Wang,Yi Ting
;
Tan,Jieqiong
;
Feng,Du
; et al.
Favorite
|
TC[WOS]:
13
TC[Scopus]:
12
IF:
9.1
/
9.0
|
Submit date:2023/08/03
Cancer
Cardiovascular Diseases
Drug Development
Metabolic Disorders
Mitophagy
Neurodegenerative Diseases
How can machine learning and multiscale modeling benefit ocular drug development?
Review article
2023
Authors:
Wang, Nannan
;
Zhang, Yunsen
;
Wang, Wei
;
Ye, Zhuyifan
;
Chen, Hongyu
; et al.
Favorite
|
TC[WOS]:
15
TC[Scopus]:
22
IF:
15.2
/
17.6
|
Submit date:2023/06/05
Computational Pharmaceutics
In Silico modelIng & Simulation
Machine Learning
Mathematical Modeling
Molecular Modeling
Ocular Drug Development
Pharmacokinetic/pharmacodynamic Modeling
Pathological mechanisms and therapeutic strategies for Alzheimer's disease
Review article
2022
Authors:
Ju, Yaojun
;
Tam, Kin
Favorite
|
TC[WOS]:
222
TC[Scopus]:
243
IF:
5.9
/
5.2
|
Submit date:2022/03/28
Alzheimer's Disease
Drug Development
Multiple Pathologies
Pathological Pathways
Pathological mechanisms and therapeutic strategies for Alzheimer's disease
Journal article
Ju Yaojun, TAM KIN YIP. Pathological mechanisms and therapeutic strategies for Alzheimer's disease[J]. Neural Regeneration Research, 2022, 17(3), 543-549.
Authors:
Ju Yaojun
;
TAM KIN YIP
Adobe PDF
|
Favorite
|
TC[WOS]:
222
TC[Scopus]:
246
IF:
5.9
/
5.2
|
Submit date:2024/08/29
Alzheimer’s Disease
Pathological Pathways
Drug Development
Multiple Pathologies